Stifel Financial’s Genomic Health, Inc. GHDX Stock Holding History

Stifel Financial’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,012	Closed	-$271K	–	3145
2019 Q3	$271K	Buy	4,012 +40	+1%	+$2.75K	﹤0.01%	2501
2019 Q2	$232K	Sell	3,972 -306	-7%	-$18.1K	﹤0.01%	2640
2019 Q1	$299K	Buy	+4,278	New	+$317K	﹤0.01%	2365

Stifel Financial's GHDX Position: Q4 2019 in Review

Stifel Financial sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,012 shares — an estimated $271K sold.

Stifel Financial first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $299K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Stifel Financial reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Stifel Financial sold 4,012 Genomic Health, Inc. shares in Q4 2019, an estimated $271K.
Stifel Financial first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
Stifel Financial's Genomic Health, Inc. position peaked at $299K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Stifel Financial's 13F filing for Q4 2019, filed 13 Feb 2020.